オセルタミビルは一般にタミフルという商品名で知られており、A型およびB型インフルエンザウイルスによるインフルエンザ（かぜ）感染の治療と予防に使用される抗ウイルス薬です。ノイラミニダーゼ阻害薬として知られる薬剤のクラスに属します。オセルタミビルは、ノイラミニダーゼ酵素の活性を阻害することで作用します。ノイラミニダーゼ酵素は、インフルエンザウイルスが体内の他の細胞に感染し、拡散するために不可欠な酵素です。オセルタミビルは、インフルエンザの症状の重症度や期間を軽減し、肺炎などのインフルエンザに関連する合併症のリスクも低下させます。オセルタミビル市場が拡大しているのは、インフルエンザウイルス感染の有病率の上昇や研究開発活動の活発化などの要因によるものです。
インフルエンザウイルスへの感染は一般的になってきています。インフルエンザは人々の病気や死亡の大きな原因であることが知られているため、経済的・医療的負担を軽減するための治療法が開発・実施されています。例えば、米国疾病予防管理センターのデータによると、2021年10月初旬から2022年6月中旬にかけて、インフルエンザウイルス感染により800万〜1,300万人の症候性疾患、370万〜610万人の医療機関受診、8万2,000〜17万人の入院、5,000〜1万4,000人の死亡が発生しています。280万人以上の呼吸器検体が臨床検査室でインフルエンザウイルスの検査を受けました。インフルエンザAは98.6％、インフルエンザBは1.4％が陽性となり、全体の4.5％を占めました。インフルエンザ陽性は1週間あたり0.1％から9.9％の検体でみられました。さらに、2021年2月に発表されたWHOの統計によると、2021年から2022年にかけて、WHO GISRS検査室によって約490,516検体が分析されました。このうち、1万2,368検体がインフルエンザ陽性と判定され、8,423検体がA型インフルエンザ、3,945検体がB型インフルエンザでした。その結果、人口におけるインフルエンザ感染の高い有病率は、その治療薬オセルタミビルの需要を高め、市場の拡大を促進すると予想されます。さらに、オセルタミビルへのアクセスを向上させる政府の取り組みや医療支出の増加が、市場成長の有利な機会を生み出しています。しかし、オセルタミビル治療に伴う副作用や代替治療法の利用可能性が、2023年から2030年の予測期間を通じて市場の成長を阻害しています。
世界のオセルタミビル市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。アメリカは、主要な市場参入企業の優位性、疾病の新興国市場の発展、確立された医療インフラの存在、研究開発活動への支出の増加により、2022年の市場を独占しました。一方、アジア太平洋は、有病率の上昇、医薬品開発のための政府資金の増加、同地域における医療支出の増加などの要因により、大きな成長を遂げると予測されています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Oseltamivir Market, by Region, 2020-2030 (USD Billion)
1.2.2. Oseltamivir Market, by Product, 2020-2030 (USD Billion)
1.2.3. Oseltamivir Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Oseltamivir Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Oseltamivir Market Dynamics
3.1. Oseltamivir Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of influenza virus infections
3.1.1.2. Increase in the number of research and development activities
3.1.2. Market Challenges
3.1.2.1. The side effects associated with oseltamivir treatment
3.1.2.2. Availability of alternative treatments
3.1.3. Market Opportunities
3.1.3.1. Government initiatives to increase access to oseltamivir
3.1.3.2. Rising healthcare expenditures
Chapter 4. Global Oseltamivir Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Oseltamivir Market, by Product
5.1. Market Snapshot
5.2. Global Oseltamivir Market by Product, Performance - Potential Analysis
5.3. Global Oseltamivir Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Oseltamivir Market, Sub Segment Analysis
5.4.1. Capsule
5.4.2. Suspension
5.4.3. Other Product Types
Chapter 6. Global Oseltamivir Market, by Application
6.1. Market Snapshot
6.2. Global Oseltamivir Market by Application, Performance - Potential Analysis
6.3. Global Oseltamivir Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Oseltamivir Market, Sub Segment Analysis
6.4.1. Influenza A
6.4.2. Influenza B
6.4.3. Other Applications
Chapter 7. Global Oseltamivir Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Oseltamivir Market, Regional Market Snapshot
7.4. North America Oseltamivir Market
7.4.1. U.S. Oseltamivir Market
7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Oseltamivir Market
7.5. Europe Oseltamivir Market Snapshot
7.5.1. U.K. Oseltamivir Market
7.5.2. Germany Oseltamivir Market
7.5.3. France Oseltamivir Market
7.5.4. Spain Oseltamivir Market
7.5.5. Italy Oseltamivir Market
7.5.6. Rest of Europe Oseltamivir Market
7.6. Asia-Pacific Oseltamivir Market Snapshot
7.6.1. China Oseltamivir Market
7.6.2. India Oseltamivir Market
7.6.3. Japan Oseltamivir Market
7.6.4. Australia Oseltamivir Market
7.6.5. South Korea Oseltamivir Market
7.6.6. Rest of Asia Pacific Oseltamivir Market
7.7. Latin America Oseltamivir Market Snapshot
7.7.1. Brazil Oseltamivir Market
7.7.2. Mexico Oseltamivir Market
7.8. Middle East & Africa Oseltamivir Market
7.8.1. Saudi Arabia Oseltamivir Market
7.8.2. South Africa Oseltamivir Market
7.8.3. Rest of Middle East & Africa Oseltamivir Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. F. Hoffmann-La Roche Ltd
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Cipla Inc.
8.3.3. Zydus Cadila
8.3.4. NATCO Pharma Limited
8.3.5. Macleods Pharmaceuticals Ltd
8.3.6. Amneal Pharmaceuticals LLC
8.3.7. Alembic Pharmaceuticals Limited
8.3.8. Hetero Healthcare Limited
8.3.9. Lupin Limited
8.3.10. Strides Pharma Science Limited
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Oseltamivir Market, report scope
TABLE 2. Global Oseltamivir Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Oseltamivir Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Oseltamivir Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Oseltamivir Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Oseltamivir Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Oseltamivir Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Oseltamivir Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Oseltamivir Market
TABLE 70. List of primary sources, used in the study of global Oseltamivir Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Oseltamivir Market, research methodology
FIG 2. Global Oseltamivir Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Oseltamivir Market, key trends 2022
FIG 5. Global Oseltamivir Market, growth prospects 2023-2030
FIG 6. Global Oseltamivir Market, porters 5 force model
FIG 7. Global Oseltamivir Market, pest analysis
FIG 8. Global Oseltamivir Market, value chain analysis
FIG 9. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Oseltamivir Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Oseltamivir Market, regional snapshot 2020 & 2030
FIG 15. North America Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 16. Europe Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Oseltamivir Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Oseltamivir Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
